These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27499265)

  • 1. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
    Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
    Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
    Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
    Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
    Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer.
    Linsalata M; Giannini R; Notarnicola M; Cavallini A
    BMC Cancer; 2006 Jul; 6():191. PubMed ID: 16854216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
    Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
    Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
    Schaefer KL; Takahashi H; Morales VM; Harris G; Barton S; Osawa E; Nakajima A; Saubermann LJ
    Int J Cancer; 2007 Feb; 120(3):702-13. PubMed ID: 17096328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
    Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
    EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
    Yun SH; Roh MS; Jeong JS; Park JI
    Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
    Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer.
    Kwon KA; Yun J; Oh SY; Seo BG; Lee S; Lee JH; Kim SH; Choi HJ; Roh MS; Kim HJ
    Cancer Res Treat; 2016 Jan; 48(1):198-207. PubMed ID: 26130665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.
    Sabatino L; Pancione M; Votino C; Colangelo T; Lupo A; Novellino E; Lavecchia A; Colantuoni V
    World J Gastroenterol; 2014 Jun; 20(23):7137-51. PubMed ID: 24966585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
    Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
    FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome Proliferator-Activated Receptor Gamma in Obesity and Colorectal Cancer: the Role of Epigenetics.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Sci Rep; 2017 Sep; 7(1):10714. PubMed ID: 28878369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells.
    Kim CS; Park WH; Park JY; Kang JH; Kim MO; Kawada T; Yoo H; Han IS; Yu R
    J Med Food; 2004; 7(3):267-73. PubMed ID: 15383218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.